Literature DB >> 1572105

The Ontario HIV seroprevalence study of childbearing women: results from the first year of testing.

R A Coates1, J W Frank, R Arshinoff, C Major, E Wallace, M E Millson, B McLaughlin, H Demshar, R Khazen, J Garbutt.   

Abstract

The Ontario HIV Seroprevalence Study of Childbearing Women is an unliked anonymous seroprevalence study designed according to the well-established ethical and legal guidelines for such studies. Commencing in November, 1989, randomly selected neonatal heelprick specimens were tested for the presence of HIV antibodies after all identifying information had been permanently and irrevocably unlinked from the specimens. During the first year of the study 94,119 (approximately 60% of all submitted specimens) were tested. Twenty-six specimens which were repeatedly reactive by EIA were confirmed as positive for an overall crude seroprevalence rate of 2.8 per 10,000 women having live births (95% CI: 1.8-4.1). Twenty-five of the 26 confirmed seropositive results came from babies born in hospitals in the Metropolitan Toronto, Ottawa-Carlton, or Hamilton-Peel-Halton regions.

Entities:  

Mesh:

Year:  1992        PMID: 1572105

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  6 in total

1.  Periodic health examination, 1992 update: 3. HIV antibody screening. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1992-09-15       Impact factor: 8.262

2.  Access to prenatal HIV testing.

Authors:  R S Remis; D M Patrick
Journal:  CMAJ       Date:  1998-06-02       Impact factor: 8.262

3.  Prevalence of HIV infection among pregnant women in Newfoundland.

Authors:  S Ratnam; K Hogan; C Hankins
Journal:  CMAJ       Date:  1996-04-01       Impact factor: 8.262

4.  Do physicians discuss HIV testing during prenatal care?

Authors:  G Ogilvie; S Adsett; G Macdonald
Journal:  Can Fam Physician       Date:  1997-08       Impact factor: 3.275

5.  Sentinel hospital surveillance of HIV infection in Quebec. Quebec Sentinel Hospital HIV-Seroprevalence Study Group.

Authors:  M Alary; J R Joly; R Parent; M Fauvel; M Dionne
Journal:  CMAJ       Date:  1994-10-01       Impact factor: 8.262

6.  High uptake of HIV testing in pregnant women in Ontario, Canada.

Authors:  Robert S Remis; Maraki Fikre Merid; Robert W H Palmer; Elaine Whittingham; Susan M King; Natasha S Danson; Lee Vernich; Carol Swantee; Carol Major
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.